Avinger earns CE mark approval for OCT catheter system

Avinger, Inc. (Redwood City, CA) garnered CE mark approval for its Ocelot catheter system, which incorporates real-time optical coherence tomography (OCT) and targets peripheral artery disease (PAD) treatment.

The Ocelot OCT catheter system can access discrete regions of the peripheral vasculature while simultaneously providing OCT visualization for navigation through arteries. Using Ocelot's Lightbox console as an adjunct to fluoroscopy, medical professionals will—for the first time—have access to a therapeutic device that incorporates real-time intravascular guidance.

Avinger recently returned from Paraguay, where it is currently enrolling patients in the VISTA study, a single-center, non-randomized registry study designed to evaluate the safety and efficacy of Ocelot in patients with PAD. The principal investigator of this trial is Dr. Adrian Ebner of Sanitorio Italiano in Asuncion, Paraguay. Dr. John Simpson of Sequoia Hospital in Redwood City, CA, and Dr. John Pigott of Jobst Vascular Institute in Toledo, OH, also participated in this groundbreaking, first-in-man registry in Paraguay.

Commercialization of Ocelot in select European countries began on September 23, 2011. The first three commercial cases are scheduled to be performed in Italy and Germany in late September and early October. This marks a major step for the company in their commitment to providing patients with minimally invasive vascular disease treatment.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

OCT imaging improves percutaneous coronary intervention, study finds

OCT can visualize coronary arteries in patients undergoing percutaneous coronary intervention, leading to improved outcomes.

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

Optical brain imaging noninvasively measures small perfusion changes caused by visual stimulation

An optical brain imaging system can track very small, focal changes in cortical perfusion resulting from visual stimulation.


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS